A gland the size of a pea
Somewhere deep in your brain, tucked behind your eyes, sits a gland no bigger than a pea.
It is called the pituitary. And it quietly runs your hormones — growth, stress, fertility, metabolism, all of it.
When something goes wrong, it often shows up as a pituitary adenoma (a noncancerous growth on this hormone control gland). These growths are surprisingly common. Up to 1 in 10 people may have one, though most never know.
Why doctors need better maps
Doctors rely on MRI scans to find and measure these tumors.
But drawing the exact outline of a pituitary tumor by hand is slow, tedious work. Radiologists can spend 20 minutes or more on a single scan. And results differ from one expert to the next.
That matters. Surgeons need precise measurements to plan operations. Oncologists need them to track growth over time.
Where old methods fell short
For years, doctors hand-traced tumors on each MRI slice. Think of it like coloring inside very wrinkled lines — on dozens of pictures.
The old way worked, but it was exhausting and inconsistent.
Enter artificial intelligence. Specifically, a type called deep learning that can "learn" to recognize shapes after seeing thousands of examples.
How the computer learns anatomy
Imagine teaching a child to spot a dog in photos. Show them enough examples, and they learn. Deep learning works similarly.
Researchers feed AI thousands of labeled brain scans. The computer studies the pixels, the contrast, the shape. Eventually it can outline a pituitary tumor on a new scan all by itself.
The most popular AI design here is called U-Net. It scans the image, compresses it down, then rebuilds it — drawing boundaries along the way.
What the review pulled together
Researchers dug through 353 published studies. They focused on 34 that specifically used automatic or semi-automatic AI segmentation for pituitary imaging.
They compared how well each method worked using something called a Dice score. A Dice score measures how much the computer's outline overlaps with a human expert's outline. Higher is better. 100% means perfect match.
For pituitary adenomas, automatic AI methods scored anywhere from 4% to 96%.
Yes, that range is enormous. The best systems nearly matched human experts. The worst barely found the tumor at all.
For the healthy pituitary gland itself — smaller and harder to see — scores landed between 0% and 89%. Semi-automatic methods, where a human guides the AI, performed more reliably at 75% to 92%.
This gap between best and worst tells the real story — AI tools are not ready to work on their own yet.
Why results are so all over the place
Here is where it gets interesting.
Most studies failed to report basic details. Things like MRI machine strength, patient ages, tumor sizes, or even how many patients were scanned. Without this information, doctors cannot tell if an AI will work on their specific patients.
An expert view on the state of AI radiology
Radiology researchers have been pushing for years to standardize how AI imaging studies report their results.
The pattern here reflects a wider problem across medical AI. Impressive numbers in lab conditions often fail when the tool meets real-world patients with varied scanners, body types, and disease stages.
What this means if you are facing a scan
If you or a loved one needs a pituitary MRI, the scan itself will look exactly the same. AI tools mostly work behind the scenes.
Some hospitals already use AI-assisted reading to speed up measurements. But a human radiologist still reviews every result.
You do not need to ask for AI. You do need to ask whether your scan is being read at a center experienced with pituitary tumors — that matters more than any algorithm.
The honest limitations
This was a review, not a new experiment. The authors could only work with what earlier studies published.
Many of those studies were small. Some used only one MRI machine at one hospital. Few tested how the AI handled rare or giant tumors. And almost none followed patients over time to see if AI measurements matched real surgical findings.
The next generation of AI will need bigger, more diverse datasets. That means scans from patients of different ages, ethnicities, and tumor types — collected across many hospitals.
Researchers also want standardized reporting so studies can actually be compared. Only then will doctors know which tools to trust.
For now, AI is a helpful assistant in the reading room, not a replacement for a trained human eye.
